Organometallic complexes as therapeutic agents
View Patent ↗This invention comprises salophene-based metallic complexes. Included are metal-chelating analogues, and method of their preparation and use. These analogues have therapeutic activity including anticancer activity.
1. A compound of formula
Z is selected from the group consisting of C, N, O or S; and,
R is selected from the group consisting of H, amino, hydroxyl, halogens, alkyl, aryl, heteroaryl, arylalkyl, acetyl, carbamates, urea, or thiourea,
alkyl, alkenyl, alkynyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, OH, COOH, CHO, halide, NO 2 , or NH 2 , or said substituent further combined with at least one substituent selected from the group consisting of amide, urea, thiourea, CN, bicyclic amine, or bicyclicdiamine.
2. A compound of formula
B is selected from ligands such as halides, acetate, oxalates, succinate, fumarates, or tartarates;
Z is selected from the group consisting of C, N, O or S;
R is selected from the group consisting of H, amino, hydroxyl, halogens, alkyl, aryl, heteroaryl, arylalkyl, acetyl, carbamates, urea, or thiourea, alkyl, alkenyl, alkynyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, OH, COOH, CHO, halide, NO 2 , or NH 2 , or said substituent further combined with at least one substituent selected from the group consisting of amide, urea, thiourea, CN, bicyclic amine, or bicyclicdiamine;
M is Fe;
Z 1 is selected from the group consisting of O, N or S.
3. A compound of formula
4. A method of treating ovarian cancer by administering to subject a therapeutically effective dose of a compound of claim 1 , 2 , or 3 .